Drug Repositioning Strategies - Serendipity by design

Report Description
Drug repositioning has several advantages over traditional discovery-reduced cost, risk and time to market-compared with traditional discovery, providing an attractive prospect for Big Pharma, scrambling to fill pipelines in an increasingly harsh market environment. As competition to inlicense candidates drives the price of this strategy up, repositioning presents a cost effective alternative.

Scope
This report covers the following:
- An outline of what drug repositioning is, and what is driving it.
- An overview of the key players in the repositioning industry their methodologies and specialities.
- Case-studies describing a number of drugs which are or have been repositioned.
- An insight into how repositioning will change going forward.

Reasons to Purchase
Purchasing this report will enable you to:
- Understand what drug repositioning is, and why it is important.
- Become aware of who the key players in drug repositioning are and how they operate.
- Gain an insight into how drugs have been, and are being repositioned.